EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multimodal Neuroimaging‐Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi‐Cohort Analysis

Tobias R Baumeister iD, Henk-Jan Westeneng, Leonard van den Berg, Canadian ALS Neuroimaging Consortium (CALSNIC), Sanjay Kalra, Yasser Iturria-Medina

Human Brain Mapping · 2025-10 · 46 (14)

DOI: 10.1002/hbm.70341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Brain Mapping, online erschienen am 24.09.2025. Verfasst von Tobias R Baumeister und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurology and Neurosurgery Department, Montreal Neurological Institute, McGill University, Quebec, Canada. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Multimodal Imaging, Gray Matter, Neuroimaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation Brain Canada, Shelly Mrkonjic ALS Research Fund, New Investigator start-up grant from McGill University's Healthy Brains for Healthy Lives Initiative (Canada First Research Excellence Fund).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a multisystem disease with marked pathophysiological and clinical heterogeneity, making individual and objective characterization of the degree of disease progression and disease‐related subtrajectories challenging. Here, we use in vivo multimodal neuroimaging data and computational models to generate personalized indices of ALS progression and subtrajectory. We used structural and diffusion weighted imaging of 691 participants (58% ALS) from two independent ALS data sets (North American and Utrecht cohorts) to extract regional values of grey matter (DM) density and white matter (WM) microstructural integrity. Contrastive trajectory inference (cTI) allowed us to identify and separate latent, multivariate patterns in neuroimaging features highlighting ALS‐associated pathological processes, which were used to generate subject‐specific indices of disease progression and subtrajectory. Disease subtrajectories were based on distinct patterns of alterations in neuroimaging data considering subjects at different disease progression levels. The neuroimaging‐based, personalized index of disease progression is indicative of clinical symptom severity (North American: p < 0.01 and Utrecht: p < 0.01) and displays alignment with the King's College staging system ( p = 0.001 and p = 0.002). Three ALS subtrajectories were identified that displayed distinct alterations in the motor, limbic system, and widespread cortical and subcortical changes that also differed in clinical symptom manifestation. Our analysis has shown that neuroimaging data encodes subject‐specific, disease‐related patterns that can be leveraged to obtain an in vivo proxy of disease progression and putative disease subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMultimodal ImagingGray MatterNeuroimagingWhite MatterHumansMaleFemaleMiddle AgedDisease ProgressionAgedCohort StudiesAdultDiffusion Magnetic Resonance ImagingDiffusion Tensor Imaging

Stichwörter der Autor:innen

braindisease stagesubgrouping

Autor:innen und Institutionen

  • Neurology and Neurosurgery Department, Montreal Neurological Institute, McGill University, Quebec, Canada.
  • McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Quebec, Canada.
  • Ludmer Centre for Neuroinformatics, McGill University, Quebec, Canada.
  • Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Tobias R Baumeister

Förderung

  • Fondation Brain Canada
  • Shelly Mrkonjic ALS Research Fund
  • New Investigator start-up grant from McGill University's Healthy Brains for Healthy Lives Initiative (Canada First Research Excellence Fund)
  • ALS Society of Canada
  • CIHR
  • Canada Research Chairs
  • Fonds de Recherche du Québec - Santé
  • Canada First Research Excellence Fund

Zitieren

APA

Baumeister, T. R., Westeneng, H. J., van den Berg, L., Canadian ALS Neuroimaging Consortium (CALSNIC), Kalra, S., & Iturria-Medina, Y. (2025). Multimodal Neuroimaging‐Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi‐Cohort Analysis. Human Brain Mapping, 46(14). https://doi.org/10.1002/hbm.70341

Vancouver

Baumeister TR, Westeneng HJ, van den Berg L, Canadian ALS Neuroimaging Consortium (CALSNIC), Kalra S, Iturria-Medina Y. Multimodal Neuroimaging‐Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi‐Cohort Analysis. Human Brain Mapping. 2025;46(14). doi:10.1002/hbm.70341

BibTeX
@article{Baumeister2025,
  author = {Baumeister, Tobias R and Westeneng, Henk-Jan and van den Berg, Leonard and Canadian ALS Neuroimaging Consortium (CALSNIC), Canadian ALS Neuroimaging Consortium (CALSNIC) and Kalra, Sanjay and Iturria-Medina, Yasser},
  title = {Multimodal Neuroimaging‐Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi‐Cohort Analysis},
  journal = {Human Brain Mapping},
  year = {2025},
  volume = {46},
  number = {14},
  doi = {10.1002/hbm.70341}
}
Kostenlos starten →